- Home
- PAI vs INO Comparison
PAI vs INO Comparison
Compare PAI & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAI | INO |
|---|---|---|
| Founded | 1973 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 118.9M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | PAI | INO |
|---|---|---|
| Price | $12.14 | $1.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 14.3K | ★ 686.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.78% | N/A |
| EPS Growth | N/A | ★ 35.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23,060.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $11.41 | $1.30 |
| 52 Week High | $13.22 | $2.86 |
Technical Indicators
Market Signals| Indicator | PAI | INO |
|---|---|---|
| Relative Strength Index (RSI) | 27.39 | 46.88 |
| Support Level | $12.10 | $1.48 |
| Resistance Level | $12.61 | $1.78 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 5.33 | 8.39 |
Price Performance
Historical ComparisonAbout PAI Western Asset Investment Grade Income Fund Inc.
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.